版本:
中国

BRIEF-Keryx Biopharmaceuticals Q1 loss per share $0.21

May 4 Keryx Biopharmaceuticals Inc:

* Keryx Biopharmaceuticals announces first quarter 2017 financial results

* Q1 loss per share $0.21

* Q1 revenue $11.8 million versus I/B/E/S view $10.3 million

* Q1 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S

* Sees for full year 2017 net u.s. Auryxia product sales of $56 to $60 million

* Keryx biopharmaceuticals - q1 2017 net u.s. Auryxia product sales of $10.5 million versus $5.6 million in q1 of 2016 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐